Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox mechanisms in autoimmune thyroid eye disease
Francesco Buonfiglio, Katharina A. Ponto, Norbert Pfeiffer, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 5, pp. 103534-103534
Open Access | Times Cited: 12

Showing 12 citing articles:

Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 13
RBM47 as a potential therapeutic target for thyroid-associated ophthalmopathy
Ru Zhu, Fei Chen, Bowen Wang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113955-113955
Open Access
Evaluating the performance of ChatGPT in patient consultation and image-based preliminary diagnosis in thyroid eye disease
Yue Wang, Shuo Yang, Chengcheng Zeng, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Detection of novel organophosphorus flame retardants and plasticizers in children urines: Associations with oxidative stress damage and thyroid nodule risk
Shijie Chen, Liyang Pan, Ana He, et al.
Environment International (2025), pp. 109445-109445
Open Access
Oxidative Stress in Cataract Formation: Is There a Treatment Approach on the Horizon?
Jingyan Li, Francesco Buonfiglio, Ying Zeng, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1249-1249
Open Access | Times Cited: 2
A Comprehensive Review of Thyroid Eye Disease Pathogenesis: From Immune Dysregulations to Novel Diagnostic and Therapeutic Approaches
Merve Kulbay, Stuti M. Tanya, Nicolas Tuli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11628-11628
Open Access | Times Cited: 2
Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cells
Maximilian Luffy, A. Ganz, Stefanie Wagner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease
Qian Chen, Pan Yuan, Yunwei Hu, et al.
Eye and Vision (2024) Vol. 11, Iss. 1
Open Access
A novel bioassay for thyroid-blocking immunoglobulins
Augustine George, Johannes Lotz, Maximilian Luffy, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
FcRn inhibitors: Transformative advances and significant impacts on IgG-mediated autoimmune diseases
Lina Zhu, Lanjun Li, Jun Wu
Autoimmunity Reviews (2024) Vol. 24, Iss. 3, pp. 103719-103719
Closed Access
Emerging treatment strategies in dry eye disease: potential of blood-derived approaches and natural plant-based products
Lingli Kong, Jiali Sun, Razzagh Abedi-Firouzjah
Experimental Eye Research (2024), pp. 110217-110217
Closed Access
Thyroid Eye Disease
Edward von Meyer, Alisha Kamboj, Andrew R. Harrison, et al.
Elsevier eBooks (2024)
Closed Access
Page 1

Scroll to top